Stay updated on GX-I7 and Pembrolizumab in R/R TNBC Clinical Trial

Sign up to get notified when there's something new on the GX-I7 and Pembrolizumab in R/R TNBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the GX-I7 and Pembrolizumab in R/R TNBC Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The page has been updated to version v2.16.5, and the previous version v2.16.4 has been removed from the content. Additionally, a significant piece of information regarding the modernization of ClinicalTrials.gov data ingest in July 2025 has been deleted.
    Difference
    2%
    Check dated 2025-07-04T02:15:12.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    The expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.
    Difference
    1%
    Check dated 2025-06-19T19:04:41.000Z thumbnail image
  4. Check
    28 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.1 to version 2.16.2.
    Difference
    0.1%
    Check dated 2025-06-05T07:56:17.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, and API users can provide input before this change. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.
    Difference
    2%
    Check dated 2025-05-29T05:36:56.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-04-30T13:42:36.000Z thumbnail image
  8. Check
    86 days ago
    Change Detected
    Summary
    The page has been updated to include new information about Triple Negative Breast Cancer and a new version revision, while significant details regarding the study's objectives and criteria have been removed.
    Difference
    16%
    Check dated 2025-04-16T01:15:44.000Z thumbnail image

Stay in the know with updates to GX-I7 and Pembrolizumab in R/R TNBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the GX-I7 and Pembrolizumab in R/R TNBC Clinical Trial page.